Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2011, Article ID 547946, 5 pages
Clinical Study

The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy

1Department of Obstetrics and Gynecology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Barcelona, Spain
2Department of Obstetrics and Gynecology, Hospital Universitari del Mar, Universitat Autònoma de Barcelona, 08003 Barcelona, Spain
3Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, 4710-057 Braga, Portugal

Received 19 April 2011; Revised 21 July 2011; Accepted 26 July 2011

Academic Editor: Thomas Herzog

Copyright © 2011 Emma Garcia Grau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


After an ectopic pregnancy (EP) fertility decreases, mostly due to tubal factor. Hysterosalpingography (HSG) is the most cost-effective tool for tubal patency assessment. Objective. To evaluate the usefulness of a HSG after a medical treatment for an EP, in order to counsel women on the most appropriate way to conceive future pregnancies. Methods. Between 1998 and 2008, 144 patients were submitted to medical treatment for an EP and performed HSG 3 months after the event. Results. 72.2% of normal HSG, 18.8% with unilateral obstruction, 6.3% tubal patency with defect, and 2.8% bilateral obstruction. Conclusion. Routine HSG following medical treatment for an EP does not seem necessary, as it does not change the initial management in 97.2% of the cases, but might be considered in selected risk cases, permitting timely referral of patients to in vitro fertilization.